Genetic Testing in Crohn Disease: Utility in Individualizing Patient Management

Author： Mascheretti Silvia   Schreiber Stefan  

Publisher： Adis International

ISSN： 1175-2203

Source： American Journal of PharmacoGenomics, Vol.5, Iss.4, 2005-01, pp. : 213-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Management of growth retardation in the young patient with Crohn’s disease

By Ballinger Anne  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 1, 2002-01 ,pp. : 1-7

Informa Healthcare

Access to resources Recommend Favorite

Guidelines for the management of Crohn's disease

By  

Inpharma, Vol. 1, Iss. 1284, 2001-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Genetic variants and the risk of Crohn’s disease: what does it mean for future disease management?

By Török Helga-Paula   Glas Jürgen   Lohse Peter   Folwaczny Christian  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 12, 2006-08 ,pp. : 1591-1602

Informa Healthcare

Access to resources Recommend Favorite

Probiotics in the Management of Crohn's disease and Ulcerative Colitis

By  

Current Pharmaceutical Design, Vol. 20, Iss. 28, 2014-08 ,pp. : 4556-4560

Bentham Science Publishers

Access to resources Recommend Favorite

Azathioprine/infliximab: Hodgkin's disease in a patient with Crohn's disease: case report

By  

Reactions Weekly, Vol. 1, Iss. 1330, 2010-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite